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1. INTRODUCTION {#jocs14130-sec-0050}
===============

Although the duration of a systemic circulatory arrest has been significantly shortened by the novel triple‐branched stent graft implantation and the cerebrovascular perfusion technique has been modified, cerebral dysfunction is still one of the most common and serious complications resulting from Stanford type A aortic dissection (AAD) surgery in our department (with rates of complications ranging from 8.6% to 10.7%)[1](#jocs14130-bib-0001){ref-type="ref"}, [2](#jocs14130-bib-0002){ref-type="ref"}, [3](#jocs14130-bib-0003){ref-type="ref"} It is currently known that the main mechanism of postoperative cerebral dysfunction is the disbalance of oxygen metabolism in the brains of patients. Compared with conventional monitoring methods, regional cerebral oxygen saturation (rcSO~2~) can provide much earlier warning indications of cerebral hypoxia. The aim of this study was to evaluate the cerebral outcomes of patients who underwent novel triple‐branched stent graft implantation with intraoperative rcSO~2~ monitoring.

2. METHODS {#jocs14130-sec-0060}
==========

One hundred thirty‐seven consecutive patients with AAD who underwent triple‐branched stent graft implantation (manufactured by Yuhengjia Sci Tech Corp Ltd, Beijing, China) from January 2017 to June 2018 in our department were enrolled in this retrospective case‐control study (Figure [1](#jocs14130-fig-0001){ref-type="fig"}). These patients were divided into two groups: the patients in group A (n = 63) received brain protection based on intraoperative rcSO~2~ monitoring, and the patients in group B (n = 74). received conventional brain protection. The general clinical data, types of corrective surgeries, intraoperative situations (eg, the value of rcSO~2~), postoperative complications (eg, anesthesia recovery period, new onset of postoperative cerebral dysfunction), and midterm outcomes of the patients were analyzed.

![Flow Chart. The patients were divided into two groups: patients in group A received brain protection based on the intraoperative rcSO~2~ monitoring (n = 63), and patients in group B received conventional brain protection (n = 74). Thirty‐five patients were excluded from this study according to the exclusion criteria described in detail below](JOCS-34-774-g001){#jocs14130-fig-0001}

2.1. Exclusion criteria {#jocs14130-sec-0070}
-----------------------

1.Patients who were younger than 16‐years of age.2.Patients who underwent other types of procedures (eg, Sun\'s procedure).3.Patients with an abnormal preoperative consciousness.4.Patients and/or their relatives who did not agree to participate in this clinical study.5.Patients who were lost to the 20‐month follow‐up.

2.2. Diagnosis criteria of the postoperative cerebral dysfunction {#jocs14130-sec-0080}
-----------------------------------------------------------------

Postoperative cerebral dysfunction included new‐onset stroke, syncope, delirium, postoperative cognitive dysfunction (POCD), delayed emergence from anesthesia (DEA), and coma, which were confirmed by two experienced neurologists. Deeply sedated patients, confirmed by the monitoring sedation status system of the Richmond Agitation Sedation Scale (RASS),[4](#jocs14130-bib-0004){ref-type="ref"} did not receive any evaluation of cerebral function until they recovered from anesthesia.

The diagnosis of a stroke was based on the National Institutes of Health Stroke Scale.[5](#jocs14130-bib-0005){ref-type="ref"} Syncope was defined as a transient loss of consciousness and was characterized by a rapid onset, short duration, and spontaneous complete recovery.[6](#jocs14130-bib-0006){ref-type="ref"} The confusion assessment method for the intensive care unit[7](#jocs14130-bib-0007){ref-type="ref"} was applied for the evaluation of postoperative delirium (POD) and POCD. The Glasgow Coma Scale[8](#jocs14130-bib-0008){ref-type="ref"} was used to objectively define coma in the two groups of patients after their surgeries. The patients whose response to stimulation occurred more than 60 to 90 minutes after the surgeries were recognized as having a DEA,[9](#jocs14130-bib-0009){ref-type="ref"} and this diagnosis should exclude the possibility of the other types of cerebral dysfunction mentioned above.

2.3. Protocols of anesthesia {#jocs14130-sec-0090}
----------------------------

Combined intravenous inhalation anesthesia was applied in the patients. The nasopharyngeal temperature and the rectal temperature were monitored. Transesophageal echocardiography (TEE) was applied to monitor the intraoperative hemodynamics. Autologous blood transfusion was used to reduce the allogeneic blood transfusion. The balances of cerebral oxygen metabolism of the patients were measured by rcSO~2~ with the Regional Oximetry System (INVOS 5100C, Medtronic). The bispectral index (BIS), which was measured by the BIS Monitoring System (VISTA, Covidien), was used to measure the depth of anesthesia.

During the surgery, the values of scSO~2~ were maintained at or above 70% of the baseline threshold. Cerebral desaturation was defined as a decrease in the saturation value below the absolute value of 50% or 70% of the baseline for 15 seconds. The mean and minimum values of the rcSO~2~, as well as the area under the curve (AUC) of the rcSO~2~ values below the line of the previously mentioned cerebral desaturation values, were collected for further analysis.

2.4. Surgical procedure {#jocs14130-sec-0100}
-----------------------

During surgery, the arterial pressures of the upper and lower limbs were monitored. A sternal incision was performed. To establish CPB, the arterial cannula was placed in the right axillary artery and the right femoral artery, and the drainage tube was placed in the right atrium. The CPB flow rate was 2.4\~2.6 L·kg^−1^·min^−1^. Intermittent cold‐blood cardioplegia was perfused through the left and right coronary arteries for myocardial protection. The following procedures, including the triple‐branched stent graft implantation, can be found in our previous literature.[2](#jocs14130-bib-0002){ref-type="ref"}

2.5. Protocol to deal with intraoperative cerebral desaturation {#jocs14130-sec-0110}
---------------------------------------------------------------

In group A, the positions of the patients were checked first to exclude the compression of the cervical great vessels when intraoperative cerebral desaturation occurred. Then, the parameters of the mechanical ventilator (before or after CPB) or the oxygenator (during CPB) were adjusted to maintain the arterial pressure of CO~2~ (PaCO~2~) above 40 mm Hg. Metaraminol or noradrenaline was used to elevate the mean arterial pressure to above 60 mm Hg. A cardiotonic (eg, epinephrine) was administered if there was a poor cardiac index (below 2.0 L·m^−2^·min^−1^), and adequate blood volume was confirmed by TEE. The BIS value was maintained at or below 50 during the CPB to ensure that patients were in a state of deep anesthesia. Other methods to prevent cerebral hypoxia included increasing the pump flow, increasing the FiO~2~ and performing allogeneic blood transfusion. The patients in group B received conventional brain protection strategy without the guidance of intraoperative rcSO~2~ monitoring.[1](#jocs14130-bib-0001){ref-type="ref"}, [2](#jocs14130-bib-0002){ref-type="ref"}, [3](#jocs14130-bib-0003){ref-type="ref"}

2.6. Follow‐up {#jocs14130-sec-0120}
--------------

Telephone contact with the patients was maintained after discharge. Every month in the first year, the patients received echocardiographies, chest radiographies, and bilateral carotid artery Doppler examinations. At one and 3 months after surgery, the patients received aortic computed tomography angiography examinations which were then performed annually.

2.7. Statistical analysis {#jocs14130-sec-0130}
-------------------------

SPSS Statistics (version 19.0, IBM) was used for the statistical analyses. Descriptive statistical analyses, as well as Wilcoxon rank‐sum tests, were used to analyze the measurement data. The *χ* ^2^ test or the Fisher exact test was used to analyze the numerical data. The Kaplan‐Meier method was used to plot the survival curves. Statistical significance was defined as *P* \< .05.

3. RESULTS {#jocs14130-sec-0140}
==========

3.1. General clinical data {#jocs14130-sec-0150}
--------------------------

Thirty‐five patients were excluded from this study, including five cases that were younger than 16 years of age, 18 cases that underwent other types of procedures, 10 cases that were coma before surgeries, and two cases that were lost to the 20‐month follow‐up.

The primary analyses revealed that there were no significant differences between the patients in the two groups in terms of age, sex, body mass index, personal history, underlying diseases, New York Heart Association class, etiologies, ultrasound cardiogram results, preoperative complications due to aortic dissections, the scales of aortic dissections, the American Society of Anesthesiologists class and EuroSCORE II values (Table [1](#jocs14130-tbl-0001){ref-type="table"}).

###### 

Clinical data

  Category of clinical data                                                     Group A (n = 63)   Group B (n = 74)   *P* value
  ----------------------------------------------------------------------------- ------------------ ------------------ -----------
  Age                                                                           50.6 ± 14.7        50.1 ± 11.6        .612
  Sex, n (%)                                                                    .174                                  
  Male                                                                          51 (81.0)          66 (89.2)          
  Female                                                                        12 (19.0)          8 (10.8)           
  BMI                                                                           24.9 ± 3.7         24.2 ± 3.5         .346
  Active smoking, n (%)                                                         32 (50.8)          28 (37.8)          .128
  Alcoholism, n (%)                                                             6 (9.5)            7 (9.5)            .990
  Underlying diseases, n (%)                                                                                          
  Diabetes                                                                      0 (0.0)            2 (2.7)            .500
  CAD                                                                           0 (0.0)            1 (1.4)            1.000
  Cardiac reoperation                                                           0 (0.0)            3 (4.1)            .249
  Renal dysfunction                                                             1 (1.6)            3 (4.1)            .624
  History of cerebral diseases                                                  3 (4.8)            2 (2.7)            .661
  History of anemia                                                             4 (6.3)            5 (6.8)            1.000
  NYHA class, %                                                                                                       
  I                                                                             11                 19                 .681
  II                                                                            41                 43                 
  III                                                                           9                  9                  
  IV                                                                            2                  3                  
  Etiologies, n (%)                                                                                                   
  Hypertension                                                                  52 (82.5)          54 (73.0)          .182
  Others                                                                        11 (17.5)          20 (27.0)          
  UCG, n (%)                                                                                                          
  EF, %                                                                         61.2 ± 8.7         60.3 ± 7.4         .368
  Pericardial effusion,[^a^](#jocs14130-tbl1-note-0003){ref-type="fn"} n (%)    4 (6.3)            1 (1.4)            .180
  Aortic regurgitation,[^b^](#jocs14130-tbl1-note-0004){ref-type="fn"} n (%)    8 (12.7)           10 (13.5)          .888
  Preoperative complications, n (%)                                                                                   
  AMI[^c^](#jocs14130-tbl1-note-0005){ref-type="fn"}                            2 (3.2)            4 (5.4)            .687
  Lower limb ischemia                                                           11 (17.5)          9 (12.2)           .381
  Mesenteric artery infarction[^d^](#jocs14130-tbl1-note-0006){ref-type="fn"}   5 (7.9)            4 (5.4)            .732
  The scale of aortic dissection, n (%)                                                                               
  Ascending aorta                                                               4 (6.3)            3 (4.1)            .208
  Aortic arch                                                                   23 (36.5)          34 (45.9)          
  Descending aorta                                                              3 (4.8)            9 (12.2)           
  Abdominal aorta                                                               22 (34.9)          15 (20.3)          
  Common iliac artery                                                           11 (17.5)          13 (17.6)          
  ASA status, n (%)                                                                                                   
  I                                                                             0 (0.0)            0 (0.0)            .342
  II                                                                            0 (0.0)            0 (0.0)            
  III                                                                           0 (0.0)            0 (0.0)            
  IV                                                                            60 (95.2)          67 (90.5)          
  V                                                                             3 (4.8)            7 (9.5)            
  VI                                                                            0 (0.0)            0 (0.0)            
  EuroSCORE II                                                                  9.9 ± 3.6          8.9 ± 3.4          .100

*Note*: The results demonstrated that there were no significant differences between the two groups in terms of age, sex, smoking, alcoholism, underlying diseases, etiology, cardiac function, preoperative complications, or preoperative status.

Abbreviations: AMI, acute myocardial infarction; ASA, American Society of Anesthesiologists; BIS, bispectral index; BMI, body mass index; CAD, coronary artery disease; ECG, electrocardiography; EF, ejection fraction; NYHA, New York Heart Association; UCG, ultracardiography.

Serious pericardial effusion.

Serious aortic regurgitation.

Clinical manifestations, ECG, and contents of creatine kinase and troponin in the serum that were consistent with the diagnostic criteria for acute myocardial infarction.

Confirmed by superior mesenteric artery angiography.

John Wiley & Sons, Ltd.

The *χ* ^2^ test revealed that there were no significant differences in the types of surgical procedures between the patients in the two groups. The Wilcoxon rank‐sum tests also indicated that the duration of surgery, CPB, aortic cross‐clamping, moderate hypothermic circulatory arrest (MHCA) + selective cerebral perfusion (SCP), the mean value of the intraoperative BIS index, the volumes of blood loss, and perioperative allogeneic transfusion had no significant differences in the patients in these two groups (Table [2](#jocs14130-tbl-0002){ref-type="table"}).

###### 

Surgical and perioperative treatments

  Categories of perioperative treatments                Group A (n = 63)   Group B (n = 74)   *P* value
  ----------------------------------------------------- ------------------ ------------------ -----------
  Types of surgical correction, n (%)                                                         
  Aortic sinus reconstruction                           7 (11.1)           14 (18.9)          .206
  Bentall                                               5 (7.9)            8 (10.8)           .567
  Wheat                                                 1 (1.6)            1 (1.4)            1.000
  Hemiarch replacement                                  62 (98.4)          68 (91.9)          .124
  Ascending aorta replacement                           61 (96.8)          68 (91.9)          .288
  CABG                                                  0 (0.0)            1 (1.4)            1.000
  Intraoperative conditions                                                                   
  Surgery, min                                          287.1 ± 64.1       285.4 ± 48.5       .743
  CPB, min                                              139.6 ± 32.4       140.6 ± 30.3       .953
  Aortic cross‐clamping, min                            48.7 ± 7.7         50.0 ± 10.8        .168
  MHCA + SCP, min                                       16.3 ± 2.2         17.0 ± 2.5         .099
  Blood loss, mL                                        339.7 ± 144.8      408.1 ± 210.5      .155
  rcSO~2~ baseline (L), %                               63.2 ± 8.1         --                 --
  rcSO~2~ baseline (R), %                               60.2 ± 9.1         --                 --
  Avg rcSO~2~ (L), %                                    64.4 ± 6.0         --                 --
  Avg rcSO~2~ (R), %                                    61.3 ± 6.9         --                 --
  rcSO~2~ minimum, %                                    45.8 ± 12.5        --                 --
  Total time of rcSO~2~ \< 70% baseline and \>15 s, n   4.4 ± 2.6          --                 --
  Total time of rcSO~2~ \< 50% and \>15 s, n            1.3 ± 1.6          --                 --
  AUC of rcSO~2~ \< 70% (L), %min                       66.2 ± 39.5        --                 --
  AUC of rcSO~2~ \< 70% (R), %min                       50.5 ± 31.3        --                 --
  AUC of rcSO~2~ \< 50% (L), %min                       27.1 ± 32.5        --                 --
  AUC of rcSO~2~ \< 50% (R), %min                       25.8 ± 24.8        --                 --
  Avg BIS index                                         40.6 ± 9.2         38.7 ± 9.3         .191
  Perioperative allogeneic transfusion                                                        
  RBC, *µ*                                              3.3 ± 2.5          3.0 ± 3.0          .187
  PLT, *µ*                                              1.4 ± 2.1          1.0 ± 1.3          .266
  FFP, mL                                               285.8 ± 324.1      364.3 ± 413.7      .228
  CP, U                                                 1.4 ± 2.6          1.3 ± 2.7          .412

*Note*: The results demonstrated that there were no significant differences between the two groups in terms of types of surgical corrections, intraoperative conditions, BIS indexes, and perioperative allogeneic transfusions.

Abbreviations: AUC, area under curve; BIS, bispectral index; CABG, coronary artery bypass grafting; CP, cryoprecipitation; CPB, cardiopulmonary bypass; FFP, fresh frozen plasma; MHCA, moderate hypothermic circulatory arrest; PLT, platelet; RBC, red blood cell; rcSO~2~, regional cerebral oxygen saturation; SCP, selective cerebral perfusion.

John Wiley & Sons, Ltd.

3.2. Intraoperative rcSO~2~ value {#jocs14130-sec-0160}
---------------------------------

The patients in group A received intraoperative rcSO~2~ monitoring, and the baseline values of rcSO~2~ were in the normal range; the average values during the surgeries were 64.4% ± 6.0% (L) and 61.3% ± 6.9% (R), and the minimum value was 45.8% ± 12.5%. The frequency of the rcSO~2~ declined to the level of 70% of baseline (which lasted for at least 15 seconds) was 4.4 ± 2.6 times in a single operation, and the number reached a value of 1.3 ± 1.6 when the level decreased to 50% of baseline. Further analysis of the rcSO~2~ value revealed that the AUCs of the rcSO~2~ below the level of 70% of baseline were 66.2% ± 39.5% min (L) and 50.5% ± 31.3% min (R), and the AUC changed to 27.1% ± 32.5% min (L) and 25.8% ± 24.8% min (R) when the level decreased to 50% of baseline (Table [2](#jocs14130-tbl-0002){ref-type="table"}). At the beginning of the induction, an obvious peak value of rcSO~2~ could be observed due to the inhalation of 100% oxygen before intubations. Afterward, we observed a slow decline in the rcSO~2~ value, which was associated with the establishment of the CPB. The rcSO~2~ value became relatively steady until the initiation of MHCA and SCP. The duration of the low‐flow cerebral perfusion or circulatory arrest of the brain was accompanied by a conspicuous and sharp decrease in the rcSO~2~ value (Figure [2](#jocs14130-fig-0002){ref-type="fig"}). We immediately initiated the previously mentioned protocol to treat intraoperative cerebral desaturation. Some transient declines in the rcSO~2~ values could also be observed after the duration of MHCA and SCP, but the amplitudes were relatively mild and did not reach the cautionary line of 70% of baseline.

![The trendgram of intraoperative rcSO~2~ value. The trendgraph of the intraoperative rcSO~2~ values displayed the variations of the intraoperative rcSO~2~ values in one classic case of a patient who underwent a triple‐branched stent graft implantation. BL, baseline; L, left brain; MHCA, moderate hypothermic circulatory arrest; R, right brain; rsSO2, regional oxygen saturation; SCP, selective cerebral perfusion](JOCS-34-774-g002){#jocs14130-fig-0002}

3.3. Postoperative situation {#jocs14130-sec-0170}
----------------------------

Thirteen (13 of 137, 9.5%) patients with postoperative cerebral complications were observed. The Wilcoxon rank‐sum tests showed that the anesthesia recovery periods of the patients in group A were notably shorter than those of the patients in group B, and the Fisher exact test showed that there were significant differences in postoperative cerebral dysfunction between the patients in the two groups. One case of POD and one case of POCD were discovered in the patients in group A. There were two cases of new‐onset stroke, one case of syncope, two cases of delirium, one case of POCD, two cases of DEA, and two cases of coma in the patients in group B. Two patients with postoperative paraplegia were also observed in group B, but no significant differences were found between the two groups. We also discovered significant differences in intubation time, length of stay in the intensive care unit (ICU), and length of hospital stay (Table [3](#jocs14130-tbl-0003){ref-type="table"}).

###### 

Short‐term outcomes

  Category                                                                               Group A (n = 63)       Group B (n = 74)       *P* value
  -------------------------------------------------------------------------------------- ---------------------- ---------------------- -----------
  Anesthesia recovery period, h[^a^](#jocs14130-tbl3-note-0003){ref-type="fn"}           9.0 ± 4.3              12.8 ± 14.0            .050
  New‐onset stroke, n (%)                                                                0 (0.0)                2 (2.7)                .500
  Syncope, n (%)                                                                         0 (0.0)                1 (1.4)                1.000
  POD, n (%)                                                                             1 (1.6)                2 (2.7)                1.000
  POCD, n (%)                                                                            1 (1.6)                1 (1.4)                1.000
  DEA, n (%)                                                                             0 (0.0)                2 (2.7)                .500
  Coma, n (%)                                                                            0 (0.0)                2 (2.7)                .500
  Total of cerebral complications, n (%)                                                 2 (3.2)                11 (14.9)              .020
  Paraplegia, n (%)                                                                      0 (0.0)                2 (2.7)                .500
  Reoperation for bleeding, n (%)                                                        0 (0.0)                2 (2.7)                .500
  Heart dysfunction, n (%)[^b^](#jocs14130-tbl3-note-0004){ref-type="fn"}                5 (7.9)                3 (4.1)                .470
  Myocardial infarction, n (%)                                                           0 (0.0)                2 (2.7)                .500
  Lethal arrhythmia, n (%)                                                               0 (0.0)                1 (1.4)                1.000
  Renal insufficiency, n (%)[^c^](#jocs14130-tbl3-note-0005){ref-type="fn"}              7 (11.0)               7 (9.5)                .750
  Pulmonary infection, n (%)                                                             5 (7.9)                10 (13.5)              .297
  Gastrointestinal complications, n (%)[^e^](#jocs14130-tbl3-note-0006){ref-type="fn"}   4 (6.3)                6 (8.1)                .692
  Wound infection, n (%)                                                                 0 (0.0)                2 (2.7)                .500
  Sepsis, n (%)                                                                          2 (3.2)                5 (6.8)                .452
  ARDS, n (%)                                                                            2 (3.2)                2 (2.7)                1.000
  MODS, n (%)                                                                            3 (4.8)                7 (9.5)                .284
  Mechanical assistance, n (%)                                                                                                         
  IABP                                                                                   0 (0.0)                2 (2.7)                .500
  ECMO                                                                                   0 (0.0)                2 (2.7)                .500
  Thoracic drainage[^f^](#jocs14130-tbl3-note-0007){ref-type="fn"}                       469.5 ± 423.4          494.6 ± 538.9          .700
  Intubation time, h                                                                     30.3 ± 22.1            42.3 ± 27.9            .014
  Tracheotomy, n (%)                                                                     6 (9.5)                8 (10.8)               .804
  Length of ICU stay, h                                                                  58.0 ± 54.3            79.7 ± 55.5            .004
  Length of hospital stay, d                                                             19.3 ± 6.7             24.9 ± 17.3            .045
  Mortality in hospital, n (%)                                                           1 (1.6)                3 (4.1)                .624
  Mortality after discharge, n (%)                                                       0 (0.0)                2 (2.7)                .500
  Mortality after surgery, n (%)                                                         1 (1.6)                5 (6.8)                .218
  Hospital costs (RMB)                                                                   213,406.0 ± 59,481.5   238,682.3 ± 64,784.6   .019

*Note*: Patients from the rcRO~2~ group (group A) were observed to have experienced shorter anesthesia recovery periods, shorter intubation times, shorter ICU stays, shorter postoperative hospital stays, and lower rates of postoperative cerebral complications and postoperative mortalities. Patients from the rcRO~2~ group (group A) spent less money, compared with the patients in the conventional monitoring group (group B). The results demonstrated that there were no significant differences between the two groups in terms of paraplegia and non‐neurological complications after the surgeries.

Abbreviations: ARDS, acute respiratory distress syndrome; DEA, delayed emergence from anesthesia; ECMO, extracorporeal membrane oxygenation; IABP, intra‐aortic balloon pumping; ICU, intensive care unit; MODS, multiple organ dysfunction syndrome; NYHA, New York Heart Association; POCD, postoperative cognitive dysfunction; POD, postoperative delirium.

Two patients with postoperative comas were not enrolled in the analysis of recovery times.

Severe heart failure reached NYHA grades III‐IV.

Required renal replacement therapy.

Included meteorism, nausea, vomiting, abdominal pain, diarrhea, constipation, and gastrointestinal hemorrhage.

Within 48 hours after surgery.

John Wiley & Sons, Ltd.

The non‐neurological complications observed after the surgeries included reoperations for bleeding, heart dysfunction, myocardial infarction, lethal arrhythmia, renal insufficiency, pulmonary infection, gastrointestinal complications, wound infection, sepsis, acute respiratory distress syndrome, and multiple organ dysfunction syndrome. The rates of the use of intra‐aortic balloon pumping and/or extracorporeal membrane oxygenation were confirmed to be proximate between the two groups (Table [3](#jocs14130-tbl-0003){ref-type="table"}).

Six cases of death were observed in this study, including four cases that occurred in the hospital and two cases that occurred after discharge. The Fisher exact test showed that there was no significant difference in the mortalities of the patients in the two groups, but we observed a decreasing trend in mortality after the surgeries that involved intraoperative rscO~2~ monitoring. Wilcoxon rank‐sum tests also showed that patients in group A spent markedly less money than the patients in group B (Table [3](#jocs14130-tbl-0003){ref-type="table"}).

3.4. Follow‐up {#jocs14130-sec-0180}
--------------

One patient was lost to the 20‐month follow‐up and was excluded from this study. Two incidences of death after discharge (both of them occurring in group B) were observed and were attributed to low cardiac output syndrome and recrudescence of the aortic dissection.

3.5. Survival curves {#jocs14130-sec-0190}
--------------------

Survival curve analyses based on 20 months of observation revealed no significant difference in the survival rate between the patients in the two groups (Figure [3](#jocs14130-fig-0003){ref-type="fig"}).

![Survival Curve. Kaplan‐Meier plots revealed that a significant difference in the survival rates between patients in group A and patients in group B within the 20‐month follow‐up period. Group A, patients received rcSO~2~ monitoring; Group B, patients received conventional brain monitoring. log‐rank result: *χ* ^2^ = 1.518, *P* = .218](JOCS-34-774-g003){#jocs14130-fig-0003}

4. DISCUSSION {#jocs14130-sec-0200}
=============

Postoperative cerebral dysfunction is still one of the most common complications after aortic dissection surgery, and this dysfunction can dramatically affect patient outcomes.[10](#jocs14130-bib-0010){ref-type="ref"} The main mechanism of cerebral dysfunction is the disbalance of oxygen metabolism in the brains of the patients during the surgeries[11](#jocs14130-bib-0011){ref-type="ref"}, [12](#jocs14130-bib-0012){ref-type="ref"} Therefore, the conventional method for avoiding postoperative cerebral complications is to reduce the duration of MHCA + SCP to as short of a time as possible. Eight years ago, our department first reported a novel surgical procedure named triple‐branched stented graft implantation, which could be applied to cure AAD without a long duration of systemic circulatory arrest and without a large amount of intraoperative blood loss.[13](#jocs14130-bib-0013){ref-type="ref"} However, the incidence of postoperative cerebral dysfunction is still frequent and has become a key factor that limits the increase in patients' survival rates in our center.

In our study, 11 patients (11 of 74, 14.9%) with postoperative cerebral complications were observed in the conventional brain protection strategy group (group B). However, only two patients (2 of 63, 3.2%) were found to be suffering from brain deficits after the surgeries in group A. The most important demarcation between the patients of the two groups was the intraoperative rcSO~2~ monitoring, especially during the period of MHCA + SCP, and there were no significant differences in terms of clinical data, surgical treatments, and perioperative treatments. Although the survival rates of the patients after the surgeries between the two groups had no significant difference (1 of 63,1.6% vs 5 of 74,6.8%) based on the 20‐month follow‐up period, we still observed a descending trend in the mortality rates after the surgeries with the utilization of intraoperative rcSO~2~ monitoring. Nonetheless, we observed improved prognoses among patients who underwent corrective surgeries of AAD with the application of intraoperative rcSO~2~ monitoring. Since the intraoperative rcSO~2~ monitoring seemed to be critical in reducing the morbidity of the postoperative cerebral complications, rcSO~2~ monitoring was then performed as one of the routine intraoperative monitoring projects in aortic dissection surgeries after October 2017 in our center.

Compared with conventional monitoring methods, intraoperative rcSO~2~ monitoring can provide earlier warning indications of cerebral hypoxia and can promote immediate decision‐making in dealing with intraoperative cerebral desaturation.[14](#jocs14130-bib-0014){ref-type="ref"} During the period of circulatory arrest, we observed drastic declines in rcSO~2~ (Figure [2](#jocs14130-fig-0002){ref-type="fig"}) during the course of SCP, and the protocol was initiated immediately to treat the intraoperative cerebral desaturation. This event of brain hypoxia indicated that the utilization of hypothermia and SCP was not always reliable in protecting the brain from hypoxia, even if the duration of circulatory arrest was shortened to only 16.3 to 17.0 minutes by our novel procedure of triple‐branched stent graft implantation. There were several hypotheses to explain this phenomenon. First, a majority (73%) of the patients in China do not have an integral circle of Willis,[15](#jocs14130-bib-0015){ref-type="ref"} which will result in the dysfunction of cross‐circulation at the skull base. Second, intracranial artery atherosclerosis caused by uncontrolled hypertension, hyperglycemia, hypercholesterolemia, and obesity, which frequently occurred in the patients undergoing aortic dissection, may further impair the insufficient cerebrovascular cross‐circulation[16](#jocs14130-bib-0016){ref-type="ref"}, [17](#jocs14130-bib-0017){ref-type="ref"}, [18](#jocs14130-bib-0018){ref-type="ref"} Therefore, an SCP will not meet the oxygen demand of the different regions of the brain. Third, the hypothermia and CPB methods may depress the regulatory functions of blood flow in the brain and may induce cerebral ischemia during the SCP process. A normal level of perfusion pressure or blood flow rate may mask the malperfusion of the central nervous system.[19](#jocs14130-bib-0019){ref-type="ref"} Therefore, the intraoperative rcSO~2~ monitoring has been routinely used in our center during aortic surgeries since August 2017.

In the research of short‐term outcomes, we observed shorter durations of recovery and intubation time in the patents in group A, and these results can be explained to be benefits of a relatively lower rate of morbidity due to cerebral oxygen desaturation with the application of intraoperative rcSO~2~ monitoring. Therefore, it seemed reasonable that the patients in group A experienced shorter lengths of ICU stay and shorter lengths of hospital stay. Otherwise, no significant differences were detected in terms of postoperative paraplegia or nonneural complications between the patients in the two groups.

Although the monitoring of rcSO~2~ was applied in the surgeries, two patients (1 case of delirium and 1 case of POCD) with postoperative cerebral complications were discovered in this study. In addition to the side effects of the anesthetics, intraoperative stress, electrolyte disturbance, or acid‐base imbalance, we should also consider the disadvantage of rcSO~2~ monitoring, in that this monitoring only focuses on the disbalance of oxygen metabolism in the bilateral frontal lobe, and is not sensitive to the abnormal statuses in the other regions of the brain. It would be much more consummate to make use of a whole‐brain oxygen saturation monitoring method and real‐time detection of the bilateral cerebrovascular blood flow by transcranial Doppler sonography during triple‐branched stent graft implantation surgeries.[20](#jocs14130-bib-0020){ref-type="ref"} Thus, the cerebral protective effect of modified intraoperative monitoring procedures requires further validation, with larger sample sizes and more randomized controlled testing.

Furthermore, this study has several limitations. First, this retrospective case‐control and single‐center study could not ensure that the patients from the two groups received uniform therapeutic strategies. The selection bias from the subjective judgment of the physicians should not be ignored. Second, due to the small sample size, the absolute quantity of the patients with postoperative cerebral complications was relatively small and might have increased the risk of statistical errors. Third, we could not exclude the possibility of underestimated mortalities, which were attributed to the relatively short duration of the follow‐up period; therefore, a longer period of postoperative observation is required.

The novel triple‐branched stent graft implantation combined with an intraoperative cerebral protection strategy based on the rcSO~2~ monitoring could reduce the postoperative mortality and the morbidity of cerebral dysfunction. Larger sample sizes and more randomized, controlled tests are required for further validation of these procedures.
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